The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I don't think the contract will be in smaller lots as the contract goes 2 ways and the government won't want to risk losing manufacturing capacity to someone else.
And here is a example of referring to the past as opposed to future earnings.
Remember the key to multibaggers is getting in before the magic happens.
Ok. I am reading this board and I can see that there are views from what most would class as deramping. When you understand what is going on, the term for these people is traders.
Traders rely on uncertainty in daily market news and fluctuations to get in and get out each day.
If you are investing ask yourself why do they go to the trouble of posting anything at all? Well they want to buy cheap and sell at a margin higher.
As in investor the key is getting in before the action happens. This is where we are now. As a trader you want to refer to the past and any negative nugget that you can find to create uncertainty and cause people to sell.
DYOR
Do you have the link for the ones that they have approved in Kazakhstan at all?
The directors sell some shares before tax window closes and you somehow move on to people losing their jobs? Eh?
This might help Topdogbob understand what he has been invested in for so long.
Great informative post with plenty of links for you to DYOR.
Why have you called this post buy or sell and only mentioned selling in the commentary?
There's that balance you were looking for in another post. Good that ODX have the Antibody test aswell as the Antigen. No rush at all.
Roche expects demand for diagnostics to remain elevated in 2021, particularly in the first half of the year
Roche expects certain COVID-19-related tailwinds to persist, and in some cases intensify, as the vaccination programs drive down cases. Specifically, Roche identified antibody testing, population surveillance, screening and flu-COVID-19 diagnosis as activities that will drive continued demand.
Maybe I am being daft. Can you direct me to the part of Medtechdrive site where it says Roche announced in a trading statement that they expect strong demand for tests in 1st half 2021 then demand for testing to drop in 2nd half of 2021 as vaccines take effect?
Don't mind me, just checking in to see if Kevin found his evidence.
Kevin it is balanced given the Daily Fail's negative article.
Whatever happens the capacity will be used. On top of this higher margins will be generated.
All the derampers just happen to have bought back in prior to the rise. Amazing insight given previous negative views on the stock.
You have any rationale for that Kate? Or to counteract the fact that Polx are funded till approval and saved on FDA submission fee.
I do find it exciting that Stifel assisted Renx through their Nasdaq listing.
I think there will be good news off the back of the voluntary withdrawal. I am also keen to hear where we are with Mologic TT. Our patience will pay off soon.
Fully funded until approval plus saved on FDA fees. If was just a normal placing would have been same route as previous placings. Stifel helped Renx list on Nasdaq. Nasdaq listing is on it's way
Just read the Wertheim article. Very resilient man and admirable. I wouldn't sell a penny and will continue to top up here.
Thanks balanced. Will take a look shortly.
Totally agree. That is why I said if you believe in the credentials. I have been here since April 2019.
The reason people miss Multibaggers is because they go off chasing rainbows. End up being down and either trapped in another share or selling for. a loss. The market will not wait for you. When you believe in the credentials of a company why the hell would you take a risk? I am looking forward to hearing news about the Stifel plans. Remember, they helped RENX list on Nasdaq.